Skip to main content
logo
Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
4.180
+0.170 (4.24%)
May 1, 2026, 4:00 PM EDT - Market closed

IMDX Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
134215422138200
Market Cap Growth
66.21%417.89%101.13%-45.77%-80.97%21.16%
Enterprise Value
126.38205.2335.2718.5525.69171.15
Last Close Price
4.187.502.382.506.4243.40
PE Ratio
--4.55-0.51-0.67-1.86-3.01
PS Ratio
33.1653.0522.0813.7439.7591.06
PB Ratio
--6.84-3.381.011.113.07
P/TBV Ratio
-4.05-7.26-2.530.941.042.96
P/FCF Ratio
--8.48-1.96-0.87-0.76-5.24
P/OCF Ratio
--9.70-2.01-0.89-0.84-5.57
EV/Sales Ratio
31.1750.6118.7512.3426.8277.87
EV/EBITDA Ratio
--4.19-0.59-0.79-2.01-3.46
EV/EBIT Ratio
--4.01-0.58-0.74-1.43-3.19
EV/FCF Ratio
--8.09-1.66-0.79-0.51-4.48
Debt / Equity Ratio
-0.05-0.05-0.190.090.070.07
Debt / EBITDA Ratio
-0.07-0.07-0.06-0.12-0.28-0.11
Debt / FCF Ratio
-0.14-0.14-0.17-0.12-0.07-0.15
Net Debt / Equity Ratio
0.260.260.41-0.32-0.49-0.43
Net Debt / EBITDA Ratio
0.170.170.080.281.320.57
Net Debt / FCF Ratio
0.320.320.230.280.340.74
Asset Turnover
0.130.130.030.020.010.02
Inventory Turnover
4.084.115.57---
Quick Ratio
1.051.051.411.381.852.50
Current Ratio
1.271.271.621.492.112.77
Return on Equity (ROE)
229.65%229.65%-910.86%-85.23%-139.11%-129.88%
Return on Assets (ROA)
-168.07%-168.07%-111.01%-28.73%-13.86%-45.18%
Return on Invested Capital (ROIC)
-408.57%-408.57%-148.91%-38.18%-19.39%-62.00%
Return on Capital Employed (ROCE)
-246.46%-246.46%-127.83%-32.29%-15.42%-56.00%
Earnings Yield
-37.35%-22.00%-195.80%-150.00%-53.74%-33.18%
FCF Yield
-18.87%-11.79%-51.05%-114.30%-131.04%-19.08%
Buyback Yield / Dilution
-133.16%-133.16%-70.84%-38.10%-24.61%-35.80%
Total Shareholder Return
-133.16%-133.16%-70.84%-38.10%-24.61%-35.80%
Updated Mar 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q